IL-6 Receptor Antagonist Therapy for Patients Hospitalized for COVID-19-Reference-Cited by-同舟云学术

IL-6 Receptor Antagonist Therapy for Patients Hospitalized for COVID-19

Published:2021-08-10 Issue:6 Volume:326 Page:483
ISSN:0098-7484
Container-title:JAMA
language:en
Short-container-title:JAMA

Author:

Matthay Michael A.¹,Luetkemeyer Anne F.²

Affiliation:

1. Departments of Medicine and Anesthesia, Cardiovascular Research Institute, University of California, San Francisco

2. Departments of Medicine and Division of Infectious Diseases, HIV and Global Medicine, Zuckerberg San Francisco General Hospital, and the University of California, San Francisco

Publisher

American Medical Association (AMA)

Subject

General Medicine

Link

https://jamanetwork.com/journals/jama/articlepdf/2781881/jama_matthay_2021_ed_210055_1628009013.17289.pdf

Reference11 articles.

1. Association between administration of IL-6 antagonists and mortality among patients hospitalized with COVID-19: a meta-analysis.;The WHO Rapid Evidence Appraisal for COVID-19 Therapies (REACT) Working Group;JAMA

2. Dexamethasone in hospitalized patients with COVID-19.;Horby;N Engl J Med,2021

3. Baricitinab plus remdesivir for hospitalized adults with COVID-19.;Kalil;N Engl J Med,2021

4. Tofacitinib in patients hospitalized with COVID-19 pneumonia.;Guimaraes;N Engl J Med

5. Remdesivir for the treatment of COVID-19: final report.;Beigel;N Engl J Med,2020

Cited by 34 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Hemostasis correction in the treatment and rehabilitation of COVID-19 patients;Rehabilitology;2024-09-06

2. IL-13 decreases susceptibility to airway epithelial SARS-CoV-2 infection but increases disease severity in vivo;2024-07-04

3. Research Progress on Thrombosis Caused by Coagulation Disorders in Severe COVID-19 Patients;Journal of Clinical Personalized Medicine;2024

4. Machine learning-based COVID-19 acute respiratory distress syndrome phenotyping and clinical outcomes: A systematic review;Heliyon;2023-06

5. Discovery of novel papain-like protease inhibitors for potential treatment of COVID-19;European Journal of Medicinal Chemistry;2023-06